Xponance’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-12,767
| Closed | -$639K | – | 1724 |
|
|
2025
Q4 | $639K | Sell |
12,767
-2,742
| -18% | -$132K | ﹤0.01% | 845 |
|
|
2025
Q3 | $761K | Sell |
15,509
-175
| -1% | -$8.97K | 0.01% | 796 |
|
|
2025
Q2 | $812K | Sell |
15,684
-846
| -5% | -$38.9K | 0.01% | 767 |
|
|
2025
Q1 | $773K | Buy |
16,530
+153
| +0.9% | +$7.9K | 0.01% | 789 |
|
|
2024
Q4 | $839K | Buy |
16,377
+784
| +5% | +$40.6K | 0.01% | 784 |
|
|
2024
Q3 | $693K | Sell |
15,593
-114
| -0.7% | -$4.99K | 0.01% | 828 |
|
|
2024
Q2 | $631K | Sell |
15,707
-1,722
| -10% | -$65.3K | 0.01% | 839 |
|
|
2024
Q1 | $698K | Buy |
17,429
+37
| +0.2% | +$1.39K | 0.01% | 836 |
|
|
2023
Q4 | $655K | Sell |
17,392
-98
| -0.6% | -$3K | 0.01% | 835 |
|
|
2023
Q3 | $486K | Sell |
17,490
-224
| -1% | -$7.01K | 0.01% | 899 |
|
|
2023
Q2 | $536K | Sell |
17,714
-1,534
| -8% | -$44.9K | 0.01% | 882 |
|
|
2023
Q1 | $593K | Buy |
19,248
+31
| +0.2% | +$1.18K | 0.01% | 858 |
|
|
2022
Q4 | $722K | Buy |
19,217
+2,077
| +12% | +$82.4K | 0.01% | 752 |
|
|
2022
Q3 | $643K | Sell |
17,140
-67
| -0.4% | -$2.66K | 0.01% | 738 |
|
|
2022
Q2 | $620K | Buy |
17,207
+30
| +0.2% | +$1.24K | 0.01% | 774 |
|
|
2022
Q1 | $842K | Sell |
17,177
-70
| -0.4% | -$3.54K | 0.01% | 660 |
|
|
2021
Q4 | $826K | Sell |
17,247
-388
| -2% | -$18.4K | 0.01% | 691 |
|
|
2021
Q3 | $774K | Sell |
17,635
-1,075
| -6% | -$45.4K | 0.01% | 676 |
|
|
2021
Q2 | $821K | Buy |
18,710
+2,708
| +17% | +$127K | 0.02% | 683 |
|
|
2021
Q1 | $732K | Buy |
16,002
+434
| +3% | +$18.2K | 0.02% | 609 |
|
|
2020
Q4 | $504K | Buy |
15,568
+71
| +0.5% | +$2.05K | 0.01% | 740 |
|
|
2020
Q3 | $328K | Buy |
15,497
+2,306
| +17% | +$48K | 0.01% | 822 |
|
|
2020
Q2 | $271K | Buy |
+13,191
| New | +$255K | 0.01% | 863 |
|
Other funds holding SNV
Xponance's SNV Position: Q1 2026 in Review
Xponance sold out of Synovus (SNV) in Q1 2026, closing a stake of 12,767 shares — an estimated $639K sold.
Xponance first reported a position in SNV in Q2 2020 and held it in 23 quarters. The position peaked at $842K in Q1 2022. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.
- Xponance reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
- Xponance sold 12,767 Synovus shares in Q1 2026, an estimated $639K.
- Xponance first reported a position in Synovus in Q2 2020 and held it in 23 quarters.
- Xponance's Synovus position peaked at $842K in Q1 2022.
- 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.